Characterization of the functional properties of env genes from long- term survivors of human immunodeficiency virus type 1 infection

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 5306-5311

  Connor, Ruth I ^a,b   Sheridan, Kristine E ^b   Lai, Cindy ^b   Zhang, Linqi ^b   Ho, David D ^b  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; SURVIVAL TIME; VIRUS GENE; VIRUS MUTATION; VIRUS PATHOGENESIS;

EID: 0029946793     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.5306-5311.1996     Document Type: Article

References (39)

1. Cao, Y., L. Qin, L. Q. Zhang, J. T. Safrit, and D. D. Ho. 1994. Virological and immunological characterization of long-term survivors of HIV-1 infection. N. Engl. J. Med. 332:201-208.
2. Chen, B., K. Saksela, R. Andino, and D. Baltimore. 1994. Distinct modes of human immunodeficiency virus type I proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferaseencoding viruses. J. Virol. 68:654-660.
3. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
4. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
5. Connor, R. I., B. K. Chen, S. Choe, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-944.
6. Connor, R. I., and D. D. Ho. 1994. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68:4400-4408.
7. Connor, R. I., H. Mohri, Y. Cao, and D. D. Ho. 1993. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in HIV-1-infected individuals. J. Virol. 67:1772-1778.
8. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, V. A. Lawson, S. Crowe, A. Maerz, S. Sonza, J. Learmant, J. S. Sullivan, A. Cunningham, D. Dwyer, D. Dowton, and J. Mills. 1995. Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991.
9. Delwart, E., E. G. Shpaer, J. Louwagie, F. E. McCutchan, M. Grez, H. Rubsamen-Waigmann, and J. I. Mullins. 1993. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 262:1257-1261.
10. Dubay, J. W., S. R. Dubay, H.-J. Shin, and E. Hunter. 1995. Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J. Virol. 69:4675-4682.
11. Gartner, S., P. Markovits, D. M. Markovitz, M. H. Kaplan, R. C. Gallo, and M. Popovic. 1986. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215-219.
12. Greenough, T. C., M. Somasundaran, D. B. Brettler, R. M. Hesselton, A. Alimenti, F. Kirchhoff, D. Panicali, and J. L. Sullivan. 1994. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 10:395-403.
13. Harrer, E., T. Harrer, S. Buchbinder, D. L. Mann, M. Feinberg, T. Yilma, R. P. Johnson, and B. D. Walker. 1994. HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons. AIDS Res. Hum. Retroviruses 10(Suppl. 2):S77-S78.
14. Ho, D. D., M. S. C. Fung, H. Yoshiyama, Y. Cao, and J. E. Robinson. 1992. Discontinuous epitopes on gp120 important in HIV-1 neutralization. AIDS Res. Hum. Retroviruses 8:1337-1339.
15. Ho, D. D., J. A. McKeating, X. L. Li, T. Moudgil, E. S. Daar, N. C. Sun, and J. E. Robinson. 1991. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J. Virol. 65:489-493.
16. Ho, D. D., M. G. Sarngadharan, M. S. Hirsch, R. T. Schooley, T. R. Rota, R. C. Kennedy, T. C. Chanh, and V. Sato. 1987. Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J. Virol. 61:2024-2028.
17. Huang, X., L. Zhang, and D. D. Ho. 1995. Biological characterization of nef in long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 69:8142-8146.
18. Huang, Y., L. Zhang, and D. D. Ho. 1995. Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 69:93-100.
19. Kestler, H. W., D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high viral loads and for development of AIDS. Cell 65:651-662.
20. Kirchhoff, F., T. C. Greenough, D. B. Brettler, J. L. Sullivan, and R. C. Desrosiers. 1995. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:228-232.
21. Klasse, P. J., J. P. Moore, and B. A. Jameson. 1993. The interplay of the HIV-1 envelope complex, gp120 and gp41, with CD4, p. 241-266. In W. J. W. Morrow and N. L. Haigwood (ed.), HIV molecular organization, pathogenicity and treatment. Elsevier Science Publishers B.V., New York.
22. Koyanagi, Y., S. Miles, R. T. Mitsuyasu, J. E. Merrill, V. H. Vinters, and I. S. Y. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
23. Learmont, J., L. Cook, H. Dunckley, and J. S. Sullivan. 1995. Update on long-term symptomless HIV type 1 infection in recipients of blood products from a single donor. AIDS Res. Hum. Retroviruses 11:1.
24. Learmont, J., B. Tindall, L. Evans, A. Cunningham, P. Cunningham, J. Wells, R. Penny, J. Kaldor, and D. A. Cooper. 1992. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 340:863-867.
25. Levy, J. A., A. D. Hoffman, S. M. Kramer, J. A. Landis, J. M. Shimabukuro, and L. S. Oshiro. 1984. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225:840-842.
26. McCune, J. M., L. B. Rabin, M. B. Feinberg, M. Lieberman, J. C. Kosek, G. R. Reyes, and I. L. Weissman. 1988. Endoproteolytic cleavage of gp160 is required for activation of human immunodeficiency virus. Cell 53:55-67.
27. McMichael, A. J., and B. D. Walker. 1994. Cytotoxic T lymphocyte epitopes: implications for HIV vaccines. AIDS 8:S155-S173.
28. Michael, N. L., G. Chang, L. A. D'Arcy, P. K. Ehrenberg, R. Mariani, M. P. Busch, D. L. Birx, and D. H. Schwartz. 1995. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J. Virol. 69:4228-4236.
29. Moore, J. P., and D. D. Ho. 1993. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67:863-875.
30. Moore, J. P., Q. J. Sattentau, R. Wyatt, and J. Sodroski. 1994. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 68:469-484.
31. Pantaleo, G., S. Menzo, M. Vaccarezza, C. Graziosi, O. J. Cohen, J. F. Demarest, D. Montefiori, J. M. Orenstein, C. Fox, and L. K. Schrager. 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332:209-216.
32. Safrit, J. T. Personal communication.
33. Safrit, J. T., A. Y. Lee, C. A. Andrews, and R. A. Koup. 1994. A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted cytotoxic T lymphocytes from two acute seroconversion patients. J. Immunol. 153:3822-3830.
34. Sambrook, J., E. F. Fritsch and T. Maniatis. 1989. Molecular cloning: a laboratory manual. 2nd ed., p. 9.14. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
35. Schrager, L. K., J. M. Young, M. G. Fowler, B. J. Mathieson, and S. H. Vermund. 1994. Long-term survivors of HIV-I: definitions and research challenges. AIDS 8(Suppl. 1):S95-S108.
36. Stevens, C. Personal communication.
37. Syu, W.-J., W.-R. Lee, B. Du, Q.-C. Yu, M. Essex, and T.-H. Lee. 1991. Role of conserved gp41 cyteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity. J. Virol. 65:6349-6352.
38. Willey, R. L., J. S. Bonifacino, B. J. Potts, M. A. Martin, and R. D. Klausner. 1988. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA 85:9580-9584.
39. Zhang, L., Y. Huang. H. Yuan, S. Tuttleton, and D. D. Ho. Characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection. Submitted for publication.